ER Positive, HER2 Negative Breast Cancer trials recruiting in Georgia

Fewer than 3 recruiting trials found.

All ER Positive, HER2 Negative Breast Cancer trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
  NCT07647328 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · Georgia: Marietta
• Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
  NCT05846789 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta